02:12 PM EST - Abattis Bioceuticals Corp. : Announced it has entered into a non-binding letter of intent with Canadian Artesian Ice Ltd. to provide Canadian Artesian with, among other things, THC- and pesticide-free cannabidiol ("CBD") isolate, research and development services, nanoencapsulation and nanoemulsification services, analytical and regulatory services and access to Abattis's distribution and marketing channels to support the development, scalability and commercialization of a CBD-infused water for Canadian Artesian. Canadian Artesian is a bottler of Premium artesian 7.8 pH mineral water, based in Nelson, British Columbia, and is the bottler of Clearly Canadian Artesian mineral water. Pursuant to the LOI, Abattis and Canadian Artesian have agreed to negotiate in good faith the terms of a definitive research services agreement respecting the terms of their partnership.
Click here to read the full release
Abattis Bioceuticals Corp.
shares
ATT:CNX are trading
down 1.59 percent at $0.31.
